Is there a treatment necessity for lipid disorders of uremic patients?

Bernard Lacour, Jean Baptiste Roullet, Pascale Beyne, Tilman Drüeke

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


In the present review, the role of lipid disturbances is evaluated as a risk factor in the pathogenesis and the potential acceleration of atherosclerosis in uremic patients undergoing long-term hemodialysis. The alteration in high density lipoprotein composition with a decrease in high density lipoprotein cholesterol but a normal apoprotein AI content may have relevance to the atherogenetic process. Moreover, the accumulation of cholesterol-rich, very low density lipoproteins and intermediate density lipoproteins may play a major role in atherosclerosis since these degradation products of triglyceride-rich particles are considered as atherogenic. The hypothesis should be tested whether a correction of the abnormal catabolism of triglyceride-rich lipoproteins in uremic patients leads to a decrease in ischemic vascular events.

Original languageEnglish (US)
Pages (from-to)42-51
Number of pages10
JournalBlood Purification
Issue number1-3
StatePublished - 1985
Externally publishedYes


  • Atherosclerosis
  • Hemodialysis patients
  • Lipids
  • Lipoprotein anomalies
  • Uremia

ASJC Scopus subject areas

  • Hematology
  • Nephrology


Dive into the research topics of 'Is there a treatment necessity for lipid disorders of uremic patients?'. Together they form a unique fingerprint.

Cite this